Evidence map›Paper›PMID 31988101›Full record

ArticleAntimicrobial agents and chemotherapy2020

Pharmacodynamics of Meropenem against Acinetobacter baumannii in a Neutropenic Mouse Thigh Infection Model.

Mojgan Sabet, Ziad Tarazi, David C Griffith

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Guideline for antimicrobial treatment of multidrug-resistant Gram-negative infections: practice recommendations of the Brazilian Society of Infectious Diseases.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Guideline
  3. Article
  4. Deciphering meropenem persistence inAntimicrobial agents and chemotherapy · 2025
    Article
  5. Antimicrobial agents and chemotherapy · 2024
    Article
  6. Article
  7. Article
  8. Frontiers in microbiology · 2022
    Article
  9. Growth kinetics of multipleF1000Research · 2022
    Article
  10. Review
  11. Antimicrobial agents and chemotherapy · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Mojgan SabetQpex Biopharma, Inc., San Diego, California, USA.
Ziad TaraziQpex Biopharma, Inc., San Diego, California, USA.
David C GriffithQpex Biopharma, Inc., San Diego, California, USA dgriffith@qpexbio.com.
Mapp Biopharmaceutical (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsAnimalsAnti-Bacterial AgentsBacterial LoadColony Count, MicrobialDisease Models, AnimalFemaleMeropenemMiceMicrobial Sensitivity TestsAnti-Bacterial AgentsMeropenemAcinetobacter baumanniimeropenemthigh model

Identifiers

PMID31988101
PMCPMC7179318
OpenAlexW3001675276

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.